Shuhua Yi
About
Shuhua Yi is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology.
According to data from OpenAlex, Shuhua Yi has authored 119 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Genetics, 60 papers in Pathology and Forensic Medicine and 44 papers in Oncology. Recurrent topics in Shuhua Yi's work include Chronic Lymphocytic Leukemia Research (60 papers), Lymphoma Diagnosis and Treatment (58 papers) and Multiple Myeloma Research and Treatments (27 papers). Shuhua Yi is often cited by papers focused on Chronic Lymphocytic Leukemia Research (60 papers), Lymphoma Diagnosis and Treatment (58 papers) and Multiple Myeloma Research and Treatments (27 papers). Shuhua Yi collaborates with scholars based in China, United States and United Kingdom. Shuhua Yi's co-authors include Lugui Qiu, Dehui Zou, Zengjun Li, Yan Xu, Gang An, Weiwei Sui, Shuhui Deng, Mu Hao, Lugui Qiu and Junyuan Qi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
In The Last Decade
Shuhua Yi
96 papers receiving 795 citations
Peers
Shuhua Yi
Alicja Gruszka Italy
Daniel Heintel Austria
Shulamiet Wittebol Netherlands
Rocío Benito Spain
Sabino Ciavarella Italy
J. Garcia‐Vargas United States
Domenico Levato Italy
Feifei Nan China
Konrad Aumann Germany
Carrie Brownstein United States
Citations per year, relative to Shuhua Yi Shuhua Yi (= 1×)
peers
Alicja Gruszka
Countries citing papers authored by Shuhua Yi
Since
Specialization
Citations
This map shows the geographic impact of Shuhua Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuhua Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuhua Yi more than expected).
Fields of papers citing papers by Shuhua Yi
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Shuhua Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuhua Yi. The network helps show where Shuhua Yi may publish in the future.
Co-authorship network of co-authors of Shuhua Yi
This figure shows the co-authorship network connecting the top 25 collaborators of Shuhua Yi. A scholar is included among the top collaborators of Shuhua Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuhua Yi. Shuhua Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sarosiek, Shayna, Andrew R. Branagan, Simone Ferrero, et al.. (2025). Report of Consensus Panel 2 from the 12th International Workshop on the management of Bing-Neel syndrome in patients with Waldenstrom’s Macroglobulinemia. Seminars in Hematology. 62(2). 85–89.
2.
Durot, Éric, Jithma P. Abeykoon, Damien Roos‐Weil, et al.. (2025). Report of Consensus Panel 6 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on Diagnosis and Management of Transformed Waldenstrom's Macroglobulinemia. Seminars in Hematology. 62(2). 120–125.
3.
Yan, Yuting, Yin Liu, Fan Yang, et al.. (2025). Comparative analysis of patients’ characteristics, treatment, and survival outcomes in CLL from China and the United States. The Oncologist. 30(7).
4.
Yan, Yuting, Tingyu Wang, Tengteng Yu, et al.. (2025). Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study. Clinical Cancer Research. 31(10). 1856–1864.
5.
Fu, Chien‐Chung, Tian Liu, Shuhua Yi, et al.. (2025). Multi-group structure analysis and molecular docking of aptamers and small molecules: A case study of chloramphenicol. Biochemical and Biophysical Research Communications. 750. 151387–151387.
6.
Wang, Yi, Yuting Yan, Dandan Shan, et al.. (2025). Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma. Cancer Biology and Medicine. 22(2). 177–189.
7.
Liu, Wei, Xiaojuan Wang, Chunyang Wang, et al.. (2024). Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy. Journal for ImmunoTherapy of Cancer. 12(3). e008450–e008450.
8.
Yi, Shuhua, et al.. (2024). Common institutional ownership and executive pay-performance sensitivity: Mediating role of information transparency and fund occupation. Research in International Business and Finance. 74. 102695–102695.
9.
Sui, Weiwei, Tengteng Yu, Yuting Yan, et al.. (2024). CAC-MM-001: A B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Followed By Autologous Stem Cell Transplantation and Second CAR-T (CART-ASCT-CART2) in Newly Diagnosed Multiple Myeloma Patients with P53 Gene Abnormalities. Blood. 144(Supplement 1). 3386–3386.
10.
Chen, Qin, et al.. (2024). Risk factors for postpartum urinary retention: An updated systematic review and meta‐analysis. International Journal of Gynecology & Obstetrics. 168(1). 10–24.
11.
Lasica, Masa, Sikander Ailawadhi, Chengcheng Fu, et al.. (2024). Updated efficacy and safety results of BCL-2 inhibitor lisaftoclax (APG-2575) alone or combined with ibrutinib or rituximab in patients (pts) with Waldenström macroglobulinemia (WM).. Journal of Clinical Oncology. 42(16_suppl). 7078–7078.
12.
Liu, Jiahui, Yan Xu, Weiwei Sui, et al.. (2024). Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS ) in patients with newly diagnosed multiple myeloma. American Journal of Hematology. 99(4). 523–533.
13.
Song, Bin, et al.. (2024). Physical activity and sleep quality among pregnant women during the first and second trimesters are associated with mental health and adverse pregnancy outcomes. BMC Women s Health. 24(1). 455–455.
14.
Wu, Huanling, Chuanyi Wang, Haiyan Mao, et al.. (2024). Value-added bio-products extracted from straw utilized as carriers for pesticide delivery: Innovative repurposing of agricultural waste. Industrial Crops and Products. 223. 120294–120294.
15.
Xu, Yan, Wensi Li, Gang An, et al.. (2023). Promising Safety and Efficacy of Trovocabtagene Autoleucel (C-CAR088) Followed ASCT in Ultra High-Risk Multiple Myeloma (UHR-MM) Patients Who Failed or Had Suboptimal Response to Standard First Line Triplet Based Therapy. Blood. 142(Supplement 1). 6864–6864.
16.
Li, Lingna, Yuting Yan, Yan Xu, et al.. (2023). Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment. Cancer Research Communications. 3(9). 1770–1780.
17.
Chen, Robert, Alex F. Herrera, Lu Chen, et al.. (2019). Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma. Clinical Cancer Research. 26(5). 1034–1044.
18.
Li, Heng, Shuhua Yi, Wenjie Xiong, et al.. (2017). Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.. SHILAP Revista de lepidopterología. 130(2). 135–142.
19.
Yi, Shuhua, Rui Cui, Zengjun Li, et al.. (2014). Distinct characteristics and new prognostic scoring system for Chinese patients with Waldenström macroglobulinemia. Chinese Medical Journal. 127(12). 2327–2331.
20.
Zhang, Huan, et al.. (2008). Effects of 6 months exercise training on ventricular remodelling and autonomic tone in patients with acute myocardial infarction and percutaneous coronary intervention. Journal of Rehabilitation Medicine. 40(9). 776–779.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Alicja Gruszka Breakdown of academic impact, for papers by Daniel Heintel Breakdown of academic impact, for papers by Shulamiet Wittebol Breakdown of academic impact, for papers by Rocío Benito Breakdown of academic impact, for papers by Sabino Ciavarella Breakdown of academic impact, for papers by J. Garcia‐Vargas Breakdown of academic impact, for papers by Domenico Levato Breakdown of academic impact, for papers by Feifei Nan Breakdown of academic impact, for papers by Konrad Aumann Breakdown of academic impact, for papers by Carrie Brownstein